cyclopentane has been researched along with Cognition Disorders in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shui, L; Song, Z; Tai, F; Wang, S; Wu, R | 1 |
| Guo, H; Lai, J; Wang, Y; Yan, P; Yin, F; Zhang, J | 1 |
| Alkalay, D; Brandeis, R; Cohen, G; Rabinovitz, I; Raveh, L; Sonego, H; Weissman, BA | 1 |
| Auclair, AL; Bardin, L; Bruins Slot, L; Colpaert, F; Depoortère, R; Kleven, MS; Newman-Tancredi, A; Vacher, B | 1 |
| Carelli, V; Costa, N; De Vita, D; Liberatore, F; Marra, R; Rispoli, V; Rotiroti, D; Scipione, L; Tirassa, P | 1 |
1 trial(s) available for cyclopentane and Cognition Disorders
| Article | Year |
|---|---|
Caramiphen and scopolamine prevent soman-induced brain damage and cognitive dysfunction.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cognition Disorders; Cyclopentanes; Escape Reaction; Hypoxia, Brain; Male; Maze Learning; Prosencephalon; Rats; Rats, Sprague-Dawley; Reaction Time; Scopolamine; Soman; Swimming | 2002 |
4 other study(ies) available for cyclopentane and Cognition Disorders
| Article | Year |
|---|---|
Bilobalide alleviates depression-like behavior and cognitive deficit induced by chronic unpredictable mild stress in mice.
Topics: Animals; Behavior, Animal; Cognition Disorders; Corticosterone; Cyclopentanes; Depression; Discrimination Learning; Disease Models, Animal; Furans; Ginkgolides; Hypothalamo-Hypophyseal System; Male; Maze Learning; Mice; Neuroprotective Agents; Pituitary-Adrenal System; Stress, Psychological | 2016 |
The Role of Dopamine D1 and D3 Receptors in N-Methyl-D-Aspartate (NMDA)/GlycineB Site-Regulated Complex Cognitive Behaviors following Repeated Morphine Administration.
Topics: Analgesics, Opioid; Analysis of Variance; Animals; Choice Behavior; Cognition Disorders; Cyclopentanes; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Impulsive Behavior; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morphine; Opioid-Related Disorders; Quinolones; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D3; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate | 2017 |
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms.
Topics: Amnesia; Animals; Antipsychotic Agents; Behavior, Animal; Benzofurans; Benzylamines; Cognition Disorders; Cyclopentanes; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Models, Animal; Phencyclidine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D3; Receptors, Dopamine D4; Reflex; Reflex, Startle; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin Receptor Agonists | 2007 |
Choline pivaloyl ester enhances brain expression of both nerve growth factor and high-affinity receptor TrkA, and reverses memory and cognitive deficits, in rats with excitotoxic lesion of nucleus basalis magnocellularis.
Topics: Animals; Basal Nucleus of Meynert; Behavior, Animal; Brain; Choline O-Acetyltransferase; Cognition Disorders; Cyclopentanes; Electroencephalography; Functional Laterality; Gene Expression Regulation; Male; Maze Learning; Memory Disorders; Nerve Growth Factor; Neuropsychological Tests; Neurotoxicity Syndromes; Rats; Rats, Wistar; Reaction Time; Receptor, trkA; Time Factors | 2008 |